450 brain tumor patients reveal key survival clues
NCT ID NCT07342699
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked back at 450 people who had surgery for a rare type of brain tumor (cerebellar glioma). Researchers wanted to see if where the tumor was located and its genetic makeup could predict how much of the tumor could be safely removed and how long patients lived. The goal is to help doctors better plan treatment and predict outcomes for future patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CEREBELLAR GLIOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
West China Hospital of Sichuan University
Chengdu, Sichuan, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Brain tumor drug vorasidenib tested in everyday practice
- AI reads MRI scans to predict brain tumor type before surgery
- Brain tumor chemo delivered by pump shows promise in tiny safety trial
- New PET scan could slash radiation by 100x
- SmartMatch: could a lab test find the right drug for your brain tumor?
- Can this drug cross the Brain's barrier to fight tumors?